Evidence map›Paper›PMID 38124994›Full record

ArticleRespiratory medicine case reports2023

Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy.

Ai Koike, Masako Arimura-Omori, Shuyo Umeda, Akihisa Takano, Yasuyuki Kishikawa, Satoshi Nakamura, Yuriko Takahata, Yuki Okamatsu, Akitaka Fujita, Taishi Harada

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ai KoikeDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Masako Arimura-OmoriDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Shuyo UmedaDepartment of Surgery, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Akihisa TakanoDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Yasuyuki KishikawaDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Satoshi NakamuraDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Yuriko TakahataDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Yuki OkamatsuDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Akitaka FujitaDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Taishi HaradaDepartment of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Fukuoka, Japan.
Kyushu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of a 45-year-old woman diagnosed with interstitial pneumonia (IP) during a comprehensive breast cancer evaluation. Although the patient showed no obvious clinical symptoms of polymyositis or dermatomyositis, the presence of anti-glycyl-transfer ribonucleic acid synthetase antibodies confirmed anti-synthetase syndrome. The patient began methylprednisolone for treatment of the IP. She then received preoperative chemotherapy with epirubicin and cyclophosphamide before undergoing a mastectomy. A significant improvement was seen in the patient's IP during treatment. This case emphasizes the potential advantages of personalized immunosuppressive therapy for patients who are simultaneously diagnosed with anti-synthetase syndrome and cancer.

Indexed as

Anti-EJ antibodyAnti-synthetase syndromeBreast cancerInterstitial pneumonia

Identifiers

PMID38124994
PMCPMC10730374
OpenAlexW4389044616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.